Delcath Systems, Inc. — Earnings Quality Grade A
DCTH · Healthcare
Strong financial health
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 50 days, change -57 days YoY
AR growth 7.8% vs revenue growth 129.1%
Revenue 129.1%, CFFO 220.5%. Cash follows revenue
Expense Quality
Inventory 47.9% vs COGS 90.6%. Normal
CapEx growth 176.7% vs revenue 129.1%. Normal
SG&A/Gross Profit = 59.3%. Normal
Gross margin 86.2%, change +2.8pp. Stable
Cash Flow Quality
CFFO/NI = 8.34. Profits backed by cash
FCF $0.0B, FCF/NI = 7.77
Accruals ratio = -16.0%. Low accruals
Cash $0.1B covers debt $0.0B
Balance Sheet Health
No goodwill. Clean balance sheet
Debt/EBITDA = 0.9x. Healthy
Insufficient data
No write-off data
Acquisition Risk
FCF after acquisitions negative for 2/3 years
No goodwill
Manipulation Score
M-Score = -2.56 (< -2.22). Unlikely manipulator
Portfolio monitoring
Monitor DCTH continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25